Fios Genomics

Fios Genomics

Analyse - Interpret - Integrate

Founded 2008

Edinburgh, United Kingdom 43 employees Series D Total: $1.85M Biotechnology

Fios Genomics, a biotechnology startup based in United Kingdom, has been providing bioinformatics services for over 15 years. The company's slogan "Analyse - Interpret - Integrate" reflects its commitment to supporting scientists, researchers, and bioinformaticians in data analysis. Fios Genomics offers a range of services, including technology/platform selection, study design, biostatistics, data QC and pre-processing, biomarker identification and validation, genomic signature development, data visualization, preclinical safety and toxicology investigations, clinical trial analysis, and drug repurposing. One of the key highlights of Fios Genomics is its proprietary computer solutions that enable the parallelization of large dataset analysis, saving processing time and streamlining the analysis process. The company has garnered a strong client base in the UK, Europe, and America, and is well-regarded for providing secure web reports complete with references and results. Their last investment of £550.00K was secured in a Series D investment on 09 February 2016, with TRI Cap as the investor. Fios Genomics' ability to handle diverse types of datasets for applications in drug discovery and development, diagnostics, agricultural research, veterinary medicine, and applied research across all species showcases its versatile expertise in the field of bioinformatics. As a long-standing player in the industry, the company continues to evolve and cater to the evolving needs of the biotechnology sector. For more information, interested parties can visit their website or reach out via social media or contact details provided.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	£550.00K	1	TRI Cap	09 Feb 2016
Series C	£300.00K	1	TRICAPITAL Angels Limited	16 Jun 2014
Venture Round	£500.00K	2	Archangel Investors Limited, TRICAPITAL Angels Limited	16 Sep 2013
Series B	£500.00K	2	Archangel Investors Limited, TRICAPITAL Angels Limited	19 Jun 2011

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

£550.00K

TRI Cap

09 Feb 2016

Series C

£300.00K

TRICAPITAL Angels Limited

16 Jun 2014

Venture Round

£500.00K

Archangel Investors Limited, TRICAPITAL Angels Limited

16 Sep 2013

Series B

£500.00K

Archangel Investors Limited, TRICAPITAL Angels Limited

19 Jun 2011

FAQ About Fios Genomics

Analyse - Interpret - Integrate

Fios Genomics was founded in 2008.

Fios Genomics is headquartered in Edinburgh, United Kingdom.

Fios Genomics operates in Biotechnology. Its work centres on Bioinformatics, Drug Discovery, Biostatistics and Genomic Analysis. Its customers include Pharmaceutical Companies, Biotechnology Companies and Clinical Research Organizations (CROs).

Fios Genomics has approximately 43 employees.

Fios Genomics has completed 4 funding rounds, raising a total of $1.85M. The latest funding stage is Series D.

Fios Genomics offers: Bioinformatics Services, Data Analysis, Target Triage, Biomarker Discovery.

Top alternatives and competitors to Fios Genomics include Ignota Labs, Cipherome, Inc, Epigene Labs, Svastia Genetics, ONCOCROSS Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Fios Genomics and Ignota Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Fios Genomics

Services & Products

Target Customers

Funding Rounds & Investors (4)

Fios Genomics Alternatives & Competitors

FAQ About Fios Genomics